𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EP-1200 SMOKING AND EPSTEIN-BARR VIRUS IGA ANTIBODIES (A MARKER FOR NASOPHARYNGEAL CARCINOMA) IN SINGAPORE CHINESE

✍ Scribed by Friborg, J.; Yuan, J.M.; Koh, W.P.; Wang, R.; Chan, S.H.; Melbye, M.; Yu, M.C.

Book ID
122693471
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
60 KB
Volume
103
Category
Article
ISSN
0167-8140

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Enzyme-Linked immunosorbent assay (ELISA
Enzyme-Linked immunosorbent assay (ELISA) for IgA and IgG antibodies to epstein-barr-virus ribonucleotide reductase in patients with nasopharyngeal carcinoma
✍ A. Fones-Tan; S. H. Chan; S. Y. Tsao; L. H. Gan; W. H. Tan; B. Li; P. W. Khong; πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 506 KB

661 bp coding for the carboxyl end of the large sub-unit of EBV ribonucleotide reductase was cloned into the pMal plasmid vector. Purified recombinant protein was tested in IgG and IgA ELISAs. For the IgG assay, 81 out of 100 NPC patients tested positive, whereas for the IgA assay, 60 tested positiv

Antibody to Epstein-Barr virus-specific
Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan
✍ Jen-Yang Chen; Chien-Jen Chen; Mei-Ying Liu; Show-Mei Cho; Mow-Ming Hsu; Tsong-C πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

A serological survey using antibody to Epstein-Barr virus (EBVI-specific DNase activity as a marker for the identification of patients with nasopharyngeal carcinoma (NPC) has been carried out on healthy subjects who visited Government Employees' Clinic Center (GECC) for routine health examination an

Serum and salivary IgA antibodies agains
Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma
✍ Y. T. Foong; H. M. Cheng; C. K. Sam; J. Dillner; W. Hinderer; U. Prasad πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 376 KB πŸ‘ 1 views

## Abstract The Epstein‐Barr virus nuclear antigen I (EBNA I) is the only latent EBV antigen consistently expressed in malignant tissues of the nasopharynx. A 20‐amino‐acid synthetic peptide, p107 contains a major epitope of EBNA I. We tested sera from 210 patients with nasopharyngeal carcinoma (NP